300759.SZ
康龙化成
SZSE · Healthcare · M 科研服务 · CN
CNY 44.86
−6.50%Year over year
Reported trailing growth
- Revenue
- +14.7%
- EBITDA
- —
- EBIT
- -9.9%
- EPS
- -9.3%
- Free cash flow
- -52.2%
- Operating cash flow
- +10.8%
Forward estimates
Based on analyst estimates
- Revenue
- +19.2%
- EBITDA
- +68.8%
- EPS
- +54.6%
Three-year CAGR
- Revenue
- +11.1%
- EBITDA
- +9.4%
- EBIT
- +4.5%
- Net income
- +6.6%
- EPS
- +6.8%
- Free cash flow
- +3.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026